PersonGen BioTherapeutics (Suzhou) Co., Ltd. Report issue

For profit Phase 1 Phase 2
Founded: Suzhou China (2010)

Organization Overview

First Clinical Trial
2015
NCT02587689
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

PersonGen BioTherapeutics (Suzhou) Co., Ltd.